2018 BIO International Convention - Tagged with Session Types

Achieving Success with the Build-to-Buy Model

1:00 PM–2:15 PM Jun 4, 2018

Dr. Abi BarrowInterim Executive Director atOffice of Technology Commercialization and Ventures at the University of Massachusetts Paul GraysonPresident & CEO atBird Rock Bio, Inc. Daniel KempSenior Director atTakeda Pharma Vertrieb GmbH & Co. KG Dr. Alicia LeveyVice President of Business Development and Strategy atTempest Therapeutics Ms. Rama Padmanabhan, JDPartner atCooley Mr. Adam SimpsonPresident and CEO atPvP Biologics

An Investor’s Perspective on Value of New Biotherapeutics

10:30 AM–11:45 AM Jun 7, 2018

Are Your Pharmaceutical Patents at Risk?

Mr. Michael AbramsManaging Partner atNumerof & Associates, Inc. Mr. Josh Franklin, MBA,MHASenior Vice President, Marketing and Corporate Development atChiesi USA, Inc. Dr. Karen HongSenior Investment Director atTakeda Ventures, Inc. Mr. Joshua SchaferGM, International and VP, Business Development and Licensing atMallinckrodt Pharmaceuticals

Intellectual Property

1:45 PM–2:45 PM Jun 6, 2018

Room 208, Level 2

MJ EdwardsSenior Counsel, Intellectual Property atGilead Sciences Dr. Justin Huddleson, PhD,JDIP Attorney, Business Development & Licensing and M&A atSanofi Rob Sahr, PhDCounsel atChoate Hall & Stewart Mary TillSr. Legal Advisor atOffice of Patent Legal Administration, USPTO

Digital Health

Artificial intelligence and machine learning: just buzzwords or breakthroughs that will truly accelerate biotech innovation?

1:15 PM–2:15 PM Jun 7, 2018

Room 210C, Level 2

Chris BenkoCEO atKoneksa Health Aman BhandariVP, Data Strategy and Solutions atVertex Pharmaceuticals Dina Katabi, PhDProfessor atMassachusetts Institute of Technology Maya Said, ScDPresident and CEO atOutcomes4Me Rachel ShaVice President, Digital Business Development & Licensing atSanofi

Balancing Access to Medicines in the Developing World with the Realities of Pharmaceutical Development

2:30 PM–3:45 PM Jun 4, 2018

Mr. Gregg AltonEVP for International Operations and Corporate Affairs atGilead Sciences, Inc. Ms. Kiran Mazumdar-ShawChairperson and Managing Director atBiocon Limited Girish SahniSecretary Department of Scientific and Industrial Research & DG-CSIR atGovernment of India Dr. Stephen SammutFounder and President atPangea University for the Health Sciences Mark WuAssistant Professor atHarvard Law School

BARDA Wants YOU! Secrets of Working With the Grant-Funding Powerhouse

4:00 PM–5:00 PM Jun 4, 2018

Corporate Best Practices & Leadership

Leah Lipsich, PhDVice President, Strategic Program Direction atRegeneron Pharmaceuticals Thomas Lowery, PhDChief Scientific Officer atT2 Biosystems Jacob M., PhDChief Scientific Officer atLovelace Biomedical Mike WatsonSVP Vaccine Partnerships & Health Impact atModerna Therapeutics

Best Practices for Working with Patient Advocacy Organizations

3:00 PM–4:00 PM Jun 6, 2018

Room 204AB, Level 2

Hilary HansenExecutive Director, Advocacy and Strategic Alliances atMerck Serena HungSenior Medical Director, Neurology Franchise atWave Jessica Riviere, MHSSenior Director of Global Patient Advocacy atBiogen Karlin Schroeder, MADirector, Community Engagement atParkinson's Foundation

Biotechnology Financing, Deal-Making and State of the Industry: Findings from EY Industry Analysis

1:45 PM–2:45 PM Jun 5, 2018

Room 257AB, Level 2

Ms. Katrine BosleyCEO atEditas Medicine Jean-Francois FormelaPartner atAtlas Ventures Glen GiovannettiGlobal Biotechnology Leader atErnst & Young John Maraganore, PhDChief Executive Officer atALNYLAM PHARMACEUTICALS Dennis J. PurcellFounder and Senior Advisor atAisling Capital

Corporate Best Practices & Leadership

Board Diversity in Practice: How Great Companies Encourage Gender Diversity at the Top

3:00 PM–4:00 PM Jun 5, 2018

Room 259A, Level 2

Morgen AldenDirector of Key Opinion Leader (KOL) Strategy and Management atLifeSci Advisors Renee ConnollyHead of Communications and Corporate Responsibility atEMD Millipore Dr. Dimitra Georganopoulou, PhDBoard Member - Past President atNorthwestern INVO Ryan MudawarDirector, Academic and Workforce Programs atMassachusetts Life Sciences Center Rick WinninghamChairman and Chief Executive Officer atTheravence

Personalized Medicine & Diagnostics

Bridging the Gap. Adding Dynamics to the Diagnostic and Therapeutic Interface

10:30 AM–11:45 AM Jun 7, 2018

Room 259B, Level 2

Dr. Roberto B., PhDChief Business Officer atCeres Nanosciences, LLP Dr. Alice JacobsAdvisor to VC companies atEIR at CalTech Prof. Adam MarshCSO atGenome Profilling LLC Ian WrightStrategic Advisor, Cedars Sinai Precision Biomarker Laboratory atCedars-Sinai

Capital. Collaboration. Complication? Stories from the CEO and CVC Perspective

4:30 PM–5:30 PM Jun 5, 2018

Room 257AB, Level 2

Margarita ChavezManaging Director, Venture Investments atAbbVie Dr. Elaine JonesVP, Venture Capital atPfizer Inc. Dr. Margi McLoughlinExecutive Director. WWBD atPfizer Inc. Dr. Marian NakadaVice President, Venture Investments atJohnson and Johnson Innovation James Rosen, MBA,MSPHCEO atArtizan Biosciences Jay Short, PhDCEO atBioAtla Praveen Tipirneni, MDCEO atMorphic Therapeutics

Translational Research

Changing the Rules for Drug Development: Innovative R&D Models that Harness Innovation and Deliver Value

3:00 PM–4:00 PM Jun 5, 2018

Room 206AB, Level 2

Mr. Chris GarabedianChairman and CEO atXontogeny, LLC David GraingerCo-Founder atMedicxi Neil Kumar, PhDChief Executive Officer atBridgeBio Pharma Mr. Don SeiffertManaging Editor atBoston business Journal Daphne ZoharFounder & CEO atPureTech Health

Cutting Waste in the Link Between Big Pharma and Payers with Precision Medicine

4:00 PM–5:00 PM Jun 4, 2018

Data Standardization in Digital Biomarkers

Edward Abrahams, PhDPresident atPersonalized Medicine Coalition Colin HillCEO, Chairman and Co-Founder atGNS Healthcare Dr. Peter JuhnVice President and Head of Global Value-based Partnerships atAmgen Mr. Casey RossNational Correspondent atStat News Dr. Michael ShermanChief Medical Officer & Senior Vice President atHarvard Pilgrim Health Care

Digital Health

11:00 AM–12:00 PM Jun 6, 2018

Room 210C, Level 2

Dr. Zachary Beattie, PhDAssistant Professor of Neurology atOregon Health & Science University Dr. Mahesh FuldeoreHead, Patient Centered Outcomes & Digital Health; Sr. Director, HEOR atAbbVie Dr. Daniel KarlinHead of Clinical, Informatics, and Regulatory Strategy, Digital Medicine and the Pfizer Innovation Research Lab atPfizer Greg PlanteDigital Health & Technology Principal atIQVIA Dr. Stephen Wicks, PhDPrincipal Data Scientist atClarivate Analytics, LLC

Next Generation Biotherapeutics

Designer Viruses

3:00 PM–4:00 PM Jun 5, 2018

Room 210B, Level 2

Dr. Ben Chan, PhDAssociate Research Scientist atYale University, Department of Ecology and Evolutionary Biology Dr. David P., PhDCSO atAmerican Gene Technologies International Inc. Dr. Samuel Rabkin, PhDThomas A. Pappas Professor of Neurosciences Department of Neurosurgery (Microbiology & Immunobiology) atHarvard Medical School Dr. Ronald Reisler, MDSenior Clinical Advisor atThe Tauri Group; Joint Project Manager, Medical Countermeasure Systems

Developing a Path to Value-Based Payment for Transformative Therapies

11:00 AM–12:00 PM Jun 5, 2018

Digital Transformation in the Life Sciences

Ms. Katrine BosleyCEO atEditas Medicine Dr. Gregory DanielDeputy Director for Policy atDuke-Margolis Center for Health Policy Marianne Hamilton LopezResearch Director atDuke-Robert J. Margolis, MD, Center for Health Policy Paul LevesqueGlobal President, Rare Disease atPfizer Dr. Michael ShermanChief Medical Officer & Senior Vice President atHarvard Pilgrim Health Care

Digital Health

12:00 PM–1:00 PM Jun 7, 2018

Room 210C, Level 2

Adlai GoldbergPrincipal atEY Dr. Daniel KarlinHead of Clinical, Informatics, and Regulatory Strategy, Digital Medicine and the Pfizer Innovation Research Lab atPfizer Dr. Karsten Risch, MD,MPH,PhDChief Medical Officer atHavas Health Dr. Francoise SimonProfessor/Senior Faculty atEmerita at Columbia University and Mount Sinai School of Medicine Wim SouverijnsCorporate Vice President, Global Marketing, Hematology & Oncology atCelgene

Don’t Be Foreign To Foreign Affairs — How To Broker Biopharma Strategic Alliances And Partnerships Between International Stakeholders

11:00 AM–12:00 PM Jun 6, 2018

Dr. Gideon Bollag, PhDCEO atPlexxikon Dr. Sophie Kornowski-Bonnet, MBA,PhDGlobal Head of Roche Partnering atRoche Dr. Armon Sharei, PhDCEO atSQZ Biotech Dr. Sander Van Deventer, MD,PhDOperating Partner atForbion Partners Rob WrightChief Editor atLife Science Leader Magazine

Drawing a Line in the Sand: Rethinking Pharmacy Benefits

4:15 PM–5:15 PM Jun 6, 2018